236311000001100: Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\UK product\Virtual medicinal product\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\UK product\Virtual therapeutic moiety\Bromocriptine\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\UK product\Virtual therapeutic moiety\Bromocriptine\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\UK product\Trade family\Parlodel\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)

\Medicinal product\Product containing microbial agent\Product containing ergot alkaloid\Product containing bromocriptine\Bromocriptine\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Product containing microbial agent\Product containing ergot alkaloid\Product containing bromocriptine\Bromocriptine\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Product containing microbial agent\Product containing ergot alkaloid\Product containing bromocriptine\Product containing bromocriptine in oral dose form (medicinal product form)\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing bromocriptine\Bromocriptine\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing bromocriptine\Bromocriptine\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing bromocriptine\Product containing bromocriptine in oral dose form (medicinal product form)\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing ergot alkaloid\Product containing bromocriptine\Bromocriptine\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing ergot alkaloid\Product containing bromocriptine\Bromocriptine\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing ergot alkaloid\Product containing bromocriptine\Product containing bromocriptine in oral dose form (medicinal product form)\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing bromocriptine\Bromocriptine\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing bromocriptine\Bromocriptine\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing bromocriptine\Product containing bromocriptine in oral dose form (medicinal product form)\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing ergot alkaloid\Product containing bromocriptine\Bromocriptine\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing ergot alkaloid\Product containing bromocriptine\Bromocriptine\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing ergot alkaloid\Product containing bromocriptine\Product containing bromocriptine in oral dose form (medicinal product form)\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing bromocriptine\Bromocriptine\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing bromocriptine\Bromocriptine\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing bromocriptine\Product containing bromocriptine in oral dose form (medicinal product form)\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing bromocriptine in oral dose form (medicinal product form)\Product containing only bromocriptine in oral dose form (medicinal product form)\Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)\Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

16903501000001112 Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

42327801000001117 Parlodel 2.5mg tablets (Meda Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Is a	Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)	true	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has excipient	Edetate disodium	false	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has active ingredient	Bromocriptine mesilate	false	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has active ingredient	Bromocriptine	false	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Is a	Parlodel	true	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Bromocriptine	true	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has specific active ingredient	Bromocriptine mesilate	true	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Has basis of strength substance	Bromocriptine	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet	Is pack of	False	Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 100 tablet	Is pack of	False	Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 100 tablet	Has AMP	True	Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier
Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) 30 tablet	Has AMP	True	Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
16903501000001112	Parlodel 2.5mg tablets (Novartis Pharmaceuticals UK Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
42327801000001117	Parlodel 2.5mg tablets (Meda Pharmaceuticals Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module